Skip to main content

Advertisement

SpringerLink
Log in

Catheter-related infections in pediatric patients with cancer

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Central venous catheters (CVCs) are essential in the management of pediatric patients receiving antineoplastic therapy or bone marrow transplants, and have significantly improved their quality of life, but CVC-related infectious complications are a major source of morbidity. It has been estimated that 14–51 % of the CVCs implanted in children with malignancies may be complicated by bacteremia, and that the incidence of infections is 1.4–1.9 episodes per 1,000 CVC days. However, there are few recent data concerning the epidemiology of CVC-related infections, the prevalence of antimicrobial resistance in their etiology, or the main factors associated with an increased risk of infection by type of catheter, patient age, the type of cancer, or the presence of neutropenia. Moreover, although various new strategies have been proposed in an attempt to reduce the risk of CVC-related infections, such as catheters impregnated with antiseptics/antibiotics, lock antibiotic prophylaxis, the use of ointments at the exit site, and antithrombotic prophylaxis, their real efficacy in children has not yet been demonstrated. The management of CVC-related infections remains difficult, mainly because of the number of still open questions (including the choice of optimal antimicrobial therapy because of the increasing isolation of multiresistant bacterial strains, treatment duration, whether catheters should be removed or not, the feasibility of guidewire exchange, and the usefulness of antibiotic lock therapy) and the lack of studies of children with cancer. Only well-designed, prospective clinical trials involving pediatric cancer patients can clarify optimal prevention and treatment strategies for CVC-related infections in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Castagnola E, Molinari AC, Fratino G, Viscoli C (2003) Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol 121:233–239

    Article  PubMed  Google Scholar 

  2. Simon A, Bode U, Beutel K (2006) Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect 12:606–620

    Article  PubMed  CAS  Google Scholar 

  3. Bucki B, Tomaszewska R, Karpe J, Stoksik P, Sońta-Jakimczyk D, Szczepański T (2008) Central venous access ports in children treated for hematopoietic malignancies. Pediatr Hematol Oncol 25:751–755

    Article  PubMed  Google Scholar 

  4. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J et al (2006) Infectious complications of implantable ports and Hickman catheters in paediatric haematology–oncology patients. J Hosp Infect 62:358–365

    Article  PubMed  CAS  Google Scholar 

  5. Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J et al (2006) Catheter-associated bloodstream infections in pediatric hematology–oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28:23–28

    PubMed  Google Scholar 

  6. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al (2002) Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics 110:e51

    Article  PubMed  Google Scholar 

  7. McGee DC, Gould MK (2003) Preventing complications of central venous catheterization. N Engl J Med 348:1123–1133

    Article  PubMed  Google Scholar 

  8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45

    Article  PubMed  CAS  Google Scholar 

  9. Sitges-Serra A (1999) Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer 7:391–395

    Article  PubMed  CAS  Google Scholar 

  10. Germanakis J, Stiakaki E, Galanakis E, Christidou A, Neonakis J, Dimitriou H et al (2002) Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 34:680–682

    Article  PubMed  Google Scholar 

  11. Hachem R, Raad I (2002) Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 20:1105–1113

    Article  PubMed  Google Scholar 

  12. Cicalini S, Palmieri F, Petrosillo N (2004) Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care 8:157–162

    Article  PubMed  Google Scholar 

  13. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E (2001) Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer 37:2413–2419

    Article  PubMed  CAS  Google Scholar 

  14. Paulus SC, van Saene HK, Hemsworth S, Hughes J, Ng A, Pizer BL (2005) A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children’s Hospital, Alder Hey, UK. Eur J Cancer 41:2132–2140

    Article  PubMed  CAS  Google Scholar 

  15. Sarper N, Zengin E, Corapçioglu F, Tugay M (2006) Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices. J Pediatr Hematol Oncol 23:459–470

    Article  Google Scholar 

  16. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G et al (2008) Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 51:53–58

    Article  PubMed  Google Scholar 

  17. Castagnola E, Bandettini R, Lorenzi I, Caviglia I, Macrina G, Tacchella A (2010) Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin. Pediatr Infect Dis J 29:1047–1048

    PubMed  Google Scholar 

  18. Viscoli C, Castagnola E, Giacchino M, Cesáro S, Properzi E, Tucci F et al (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 35:770–774

    Article  PubMed  CAS  Google Scholar 

  19. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Gonçalves VM (2004) Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect 10:542–549

    Article  PubMed  CAS  Google Scholar 

  20. Castagnola E, Cesaro S, Giacchino M, Livadiotti S, Tucci F, Zanazzo G et al (2006) Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 25:634–639

    Article  PubMed  Google Scholar 

  21. Castagnola E, Conte M, Parodi S, Papio F, Caviglia I, Haupt R (2007) Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr Blood Cancer 49:672–677

    Article  PubMed  Google Scholar 

  22. Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B et al (2008) Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 41:339–347

    Article  PubMed  CAS  Google Scholar 

  23. Castagnola E, Rossi MR, Cesaro S, Livadiotti S, Giacchino M, Zanazzo G et al (2010) Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. Pediatr Blood Cancer 55:1103–1107

    Article  PubMed  Google Scholar 

  24. Downes KJ, Metlay JP, Bell LM, McGowan KL, Elliott MR, Shah SS (2008) Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis 46:387–394

    Article  PubMed  Google Scholar 

  25. Crnich CJ, Maki DG (2002) The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 34:1232–1242

    Article  PubMed  Google Scholar 

  26. Crnich CJ, Maki DG (2002) The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 34:1362–1368

    Article  PubMed  Google Scholar 

  27. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70

    Article  PubMed  Google Scholar 

  28. Fratino G, Molinari AC, Mazzola C, Giacchino M, Saracco P, Bertocchi E et al (2002) Prospective study of indwelling central venous catheter-related complications in children with Broviac or clampless valved catheters. J Pediatr Hematol Oncol 24:657–661

    Article  PubMed  Google Scholar 

  29. Cesaro S, Corrò R, Pelosin A, Gamba P, Zadra N, Fusaro F et al (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183–188

    Article  PubMed  Google Scholar 

  30. Castagnola E, Molinari AC, Giacchino M, Chiapello N, Moroni C, Caviglia I et al (2007) Incidence of catheter-related infections within 30 days from insertion of Hickman–Broviac catheters. Pediatr Blood Cancer 48:35–38

    Article  PubMed  Google Scholar 

  31. Biagi E, Arrigo C, Dell’Orto MG, Balduzzi A, Pezzini C, Rovelli A et al (1997) Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 5:228–233

    Article  PubMed  CAS  Google Scholar 

  32. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R (2005) Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 16:648–654

    Article  PubMed  CAS  Google Scholar 

  33. Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R et al (2009) Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol 27:2059–2065, Erratum in: J Clin Oncol 2010;28:708

    Article  PubMed  Google Scholar 

  34. Abbas AA, Fryer CJ, Paltiel C, Chedid F, Felimban SK, Yousef AA et al (2004) Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 42:325–331

    Article  PubMed  Google Scholar 

  35. Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA (2004) Port-A-Cath infections in children with cancer. Eur J Cancer 40:2452–2458

    Article  PubMed  CAS  Google Scholar 

  36. Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y (2007) Risk factors for early catheter-related infections in cancer patients. Cancer 110:1586–1592

    Article  PubMed  Google Scholar 

  37. Hung MC, Chen CJ, Wu KG, Hung GY, Lin YJ, Tang RB (2009) Subcutaneously implanted central venous access device infection in pediatric patients with cancer. J Microbiol Immunol Infect 42:166–171

    PubMed  Google Scholar 

  38. Wurzel CL, Halom K, Feldman JG, Rubin LG (1988) Infection rates of Broviac–Hickman catheters and implantable venous devices. Am J Dis Child 142:536–540

    PubMed  CAS  Google Scholar 

  39. Pagano L, Tacconelli E, Tumbarello M, Laurenti L, Ortu-La Barbera E, Antinori A et al (1997) Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 82:415–419

    PubMed  CAS  Google Scholar 

  40. Elihu A, Gollin G (2007) Complications of implanted central venous catheters in neutropenic children. Am Surg 73:1079–1082

    PubMed  Google Scholar 

  41. Nam SH, Kim DY, Kim SC, Kim IK (2010) Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer 54:546–551

    PubMed  Google Scholar 

  42. Junqueira BL, Connolly B, Abla O, Tomlinson G, Amaral JG (2010) Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia. Cancer 116:4368–4375

    Article  PubMed  Google Scholar 

  43. Paglialonga F, Esposito S, Edefonti A, Principi N (2004) Catheter-related infections in children treated with hemodialysis. Pediatr Nephrol 19:1324–1333

    Article  PubMed  Google Scholar 

  44. Maki DG, Ringer M, Alvarado CJ (1991) Prospective randomised trial of povidone–iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339–343

    Article  PubMed  CAS  Google Scholar 

  45. Timsit JF (2007) Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 13:563–571

    Article  PubMed  Google Scholar 

  46. van de Wetering MD, van Woensel JB (2007) Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 1:CD003295

    PubMed  Google Scholar 

  47. Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257–266

    PubMed  CAS  Google Scholar 

  48. Carratalà J (2001) Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 7(Suppl 4):83–90

    Article  PubMed  Google Scholar 

  49. Schwartz C, Henrickson KJ, Roghmann K, Powell K (1990) Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 8:1591–1597

    PubMed  CAS  Google Scholar 

  50. Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC et al (2000) Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 18:1269–1278

    PubMed  CAS  Google Scholar 

  51. Rackoff WR, Weiman M, Jakobowski D, Hirschl R, Stallings V, Bilodeau J et al (1995) A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 127:147–151

    Article  PubMed  CAS  Google Scholar 

  52. Pierce CM, Wade A, Mok Q (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 26:967–972

    Article  PubMed  CAS  Google Scholar 

  53. Abdelkefi A, Ben Romdhane N, Kriaa A, Chelli M, Torjman L, Ladeb S et al (2005) Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients. Bone Marrow Transplant 36:885–889

    Article  PubMed  CAS  Google Scholar 

  54. Abdelkefi A, Torjman L, Ladeb S, Othman TB, Achour W, Lakhal A et al (2005) Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol 23:7864–7870

    Article  PubMed  Google Scholar 

  55. Kalmanti M, Germanakis J, Stiakaki E, Syfridaki C, Christidou A, Tsetis D et al (2002) Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. Pediatr Hematol Oncol 19:173–179

    Article  PubMed  CAS  Google Scholar 

  56. Simon A, Bode U, Lieber K, Beutel K, Fleischhack G (2008) Review and update of the use of urokinase in the prevention and management of CVAD-related complications in pediatric oncology patients. Am J Infect Control 36:54–58

    Article  PubMed  Google Scholar 

  57. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R et al (2003) Minocycline–ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36:116–119

    Article  PubMed  Google Scholar 

  58. Simon A, Ammann RA, Wiszniewsky G, Bode U, Fleischhack G, Besuden MM (2008) Taurolidine–citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 8:102

    Article  PubMed  Google Scholar 

  59. Kayton ML, Garmey EG, Ishill NM, Cheung NK, Kushner BH, Kramer K et al (2010) Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections. J Pediatr Surg 45:1961–1966

    Article  PubMed  Google Scholar 

  60. Arora RS, Roberts R, Eden TO, Pizer B (2010) Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer. Cochrane Database Syst Rev 12:CD007785

    PubMed  Google Scholar 

  61. Bouza E, Burillo A, Muñoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8:265–274

    Article  PubMed  CAS  Google Scholar 

  62. Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194

    Article  PubMed  Google Scholar 

  63. Carratalà J, Niubó J, Fernández-Sevilla A, Juvé E, Castellsagué X, Berlanga J et al (1999) Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43:2200–2204

    PubMed  Google Scholar 

  64. De Sio L, Jenkner A, Milano GM, Ilari I, Fidani P, Castellano A et al (2004) Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J 23:963–965

    Article  PubMed  Google Scholar 

  65. Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J et al (2006) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58:816–821

    Article  PubMed  Google Scholar 

  66. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90–94

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This review was supported, in part, by a grant from the Italian Ministry of Health (Bando Giovani Ricercatori 2007).

Conflict of interest

The authors have no conflict of interest to declare

Author information

Authors and Affiliations

  1. Department of Biomedicine of Developmental Age, University of Bari, Bari, Italy

    V. Cecinati, L. Brescia & P. Giordano

  2. Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Via Commenda 9, 20122, Milano, Italy

    L. Tagliaferri & S. Esposito

Authors
  1. V. Cecinati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Brescia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Tagliaferri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Giordano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Esposito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cecinati, V., Brescia, L., Tagliaferri, L. et al. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis 31, 2869–2877 (2012). https://doi.org/10.1007/s10096-012-1652-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-012-1652-4

Keywords

Search

Navigation